Casselman B L, Kilgore K S, Miller B F, Warren J S
Department of Pathology, University of Michigan Medical School, Ann Arbor 48109-0602, USA.
J Lab Clin Med. 1995 Nov;126(5):495-502.
Antibodies to neutrophil cytoplasmic antigens (ANCA) have been found in the serum samples of patients with a number of vasculitides (e.g., Wegener's granulomatosis, small vessel vasculitis, and idiopathic necrotizing and cresentic glomerulonephritis). Although detection of ANCA in serum samples has proven to be useful diagnostically and in selected activity of disease monitoring situations, the pathogenetic role of ANCA in vasculitis remains ill-defined. We sought to determine whether purified ANCA promotes the secretion of monocyte chemoattractant protein-1 (MCP-1) from isolated human peripheral blood monocytes. P (perinuclear)- and C (cytoplasmic)- ANCA were purified from the serum samples of patients with either Wegener's granulomatosis, small vessel vasculitis, or idiopathic necrotizing and cresentic glomerulonephritis. Human peripheral blood monocytes from healthy subjects were incubated with either C-ANCA immunoglobulin G (IgG), P-ANCA IgG, or nonspecific IgG, and the conditioned media were analyzed for MCP-1 activity. A monocyte chemotaxis assay was utilized to functionally quantify secreted chemotactic activity. Secretion of monocyte chemotactic activity was found to be antibody concentration-dependent and time-dependent, with maximal chemotaxis measured in media collected 24 hours after the addition of either C- or P-ANCA IgG. A specific antibody directed against human MCP-1 largely inhibited monocyte chemotaxis, indicating that MCP-1 is the predominant monocyte chemotactic mediator present in the conditioned medium. An MCP-1 enzyme-linked immunosorbent assay further supported the conclusion that P- and C-ANCA IgG can trigger MCP-1 secretion by monocytes. These data indicate that incubation of monocytes with ANCA promotes the dose-dependent release of the chemotactic beta-chemokine MCP-1.(ABSTRACT TRUNCATED AT 250 WORDS)
在许多血管炎患者(如韦格纳肉芽肿、小血管血管炎和特发性坏死性新月体性肾小球肾炎)的血清样本中发现了抗中性粒细胞胞浆抗原(ANCA)抗体。尽管血清样本中ANCA的检测已被证明在诊断及某些疾病监测活动中很有用,但ANCA在血管炎中的致病作用仍不明确。我们试图确定纯化的ANCA是否能促进分离的人外周血单核细胞分泌单核细胞趋化蛋白-1(MCP-1)。从韦格纳肉芽肿、小血管血管炎或特发性坏死性新月体性肾小球肾炎患者的血清样本中纯化出核周型(P)-和胞浆型(C)-ANCA。将健康受试者的人外周血单核细胞与C-ANCA免疫球蛋白G(IgG)、P-ANCA IgG或非特异性IgG一起孵育,分析条件培养基中的MCP-1活性。采用单核细胞趋化试验对分泌的趋化活性进行功能定量。发现单核细胞趋化活性的分泌呈抗体浓度依赖性和时间依赖性,在加入C-或P-ANCA IgG后24小时收集的培养基中测得最大趋化性。一种针对人MCP-1的特异性抗体在很大程度上抑制了单核细胞趋化,表明MCP-1是条件培养基中存在的主要单核细胞趋化介质。MCP-1酶联免疫吸附试验进一步支持了P-和C-ANCA IgG可触发单核细胞分泌MCP-1的结论。这些数据表明,单核细胞与ANCA孵育可促进趋化性β趋化因子MCP-1的剂量依赖性释放。(摘要截短于250字)